Hartford Financial Management’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-720
Closed -$5.22K 396
2024
Q1
$5.22K Hold
720
﹤0.01% 330
2023
Q4
$3.61K Hold
720
﹤0.01% 346
2023
Q3
$3.03K Hold
720
﹤0.01% 350
2023
Q2
$2.9K Sell
720
-27
-4% -$109 ﹤0.01% 331
2023
Q1
$2.11K Hold
747
﹤0.01% 346
2022
Q4
$2.3K Hold
747
﹤0.01% 341
2022
Q3
$2K Hold
747
﹤0.01% 344
2022
Q2
$4K Hold
747
﹤0.01% 326
2022
Q1
$6K Buy
+747
New +$6K ﹤0.01% 314
2021
Q4
Sell
-27
Closed -$1K 359
2021
Q3
$1K Sell
27
-40
-60% -$1.48K ﹤0.01% 384
2021
Q2
$3K Sell
67
-187
-74% -$8.37K ﹤0.01% 344
2021
Q1
$12K Hold
254
﹤0.01% 285
2020
Q4
$10K Hold
254
﹤0.01% 283
2020
Q3
$6K Sell
254
-814
-76% -$19.2K ﹤0.01% 282
2020
Q2
$78K Hold
1,068
0.02% 173
2020
Q1
$56K Buy
1,068
+50
+5% +$2.62K 0.02% 179
2019
Q4
$83K Sell
1,018
-212
-17% -$17.3K 0.03% 190
2019
Q3
$70K Buy
1,230
+180
+17% +$10.2K 0.02% 194
2019
Q2
$125K Hold
1,050
0.04% 171
2019
Q1
$193K Buy
1,050
+12
+1% +$2.21K 0.07% 154
2018
Q4
$185K Sell
1,038
-20
-2% -$3.57K 0.07% 151
2018
Q3
$339K Buy
1,058
+180
+21% +$57.7K 0.11% 130
2018
Q2
$351K Buy
878
+7
+0.8% +$2.8K 0.13% 129
2018
Q1
$312K Buy
871
+67
+8% +$24K 0.16% 100
2017
Q4
$318K Buy
804
+40
+5% +$15.8K 0.16% 101
2017
Q3
$325K Buy
764
+48
+7% +$20.4K 0.16% 97
2017
Q2
$114K Hold
716
0.05% 156
2017
Q1
$89K Buy
716
+324
+83% +$40.3K 0.05% 153
2016
Q4
$48K Buy
392
+300
+326% +$36.7K 0.03% 157
2016
Q3
$13K Hold
92
0.01% 215
2016
Q2
$5K Buy
+92
New +$5K ﹤0.01% 249